7096
StemCell Institute
7096
StemCell Institute
¥ -
-
Track StemCell Institute (7096) issued, treasury and outstanding shares over time, split-adjusted, alongside annual share buyback amounts.
2026-03
2021 → 2026-03
No comparable period
2026-03
Each bar is the issued share count. Buybacks grow treasury shares; cancelling them shrinks the issued count itself.
Splits: 2023-01-01: 2-for-1 split (effective date)
※ 2023-03: 2-for-1 split. From this period, the earnings release reports post-split share counts (this can start before the effective date).
Split-adjusted restates earlier share counts on today's basis. As reported shows the figures in each earnings release, which cannot be compared across a split.
Some treasury share counts are filled from annual or quarterly reports where no earnings release exists.
Cash returned to shareholders each year: dividends paid plus share buybacks, with the total payout ratio ((dividends + buybacks) ÷ net income).
Periods without a reported amount show "—". This does not necessarily mean nothing was paid or repurchased.
Buybacks are the amount spent on repurchases; treasury shares later handed out (for example as stock compensation) are not deducted, except where a company reports a net figure. See Treasury share disposals below.
The ratio uses net income attributable to owners of the parent, for the latest five years. Loss-making years are not shown. Dividends are the cash paid during the year (including the prior year-end dividend), so the ratio may differ from the one a company publishes.
Buyback authorisations and the latest reported progress (TDnet)
Resolved 2024-12-17
Period: 2024-12-18 – 2025-11-30 · Open market
自己株式取得に係る事項の決定に関するお知らせ
Progress divides the latest reported cumulative total by the cap. The share of issued shares is the figure stated by the company.
"Status unknown" means no end date, completion filing or cap was found; it is not necessarily in progress.
A tender offer's announcement, amendments and execution are combined only when the later filing explicitly cites the earlier one.
Data as of 2026-09-30
As reported in each earnings release
2023-032-for-1 split
| Fiscal year | Issued | Treasury | Outstanding | Buybacks | Dividends paid | Source |
|---|---|---|---|---|---|---|
| 2026-03 | 10,246,600 | 176,412 | 10,070,188 | ¥106M | ¥218000 | Report |
| 2025-03 | 10,246,600 | 75,112 | 10,171,488 | ¥94M | ¥256M | Report |
| 2024-03 | 10,246,600 | 46 | 10,246,554 | — | — | Report |
| 2023-032-for-1 split | 10,246,600 | 46 | 10,246,554 | ¥91000 | — | Report |
| 2022-03 | 5,123,300 | 0 | 5,123,300 | — | — | Report |
| 2021-03 | 4,867,100 | 0† | 4,867,100† | — | — | Report |
† Filled from annual or quarterly reports for periods without an earnings release.
For dividends per share and payout ratios, see Dividends.